GlassScriptPhysician profile
Christopher D Tykocki
NPI 1568498772
$2,797.64
in general payments reported to CMS, 2019-2025
28 companies · $602 in 2025
The $602 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $160 · 2021: $195 · 2022: $529 · 2023: $559 · 2024: $460 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,601 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,601.10 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $645.39 | 2020-2025 | Vraylar, Qulipta, Liletta |
| Astellas Pharma US INC | $293.68 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $259.59 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $186.71 | 2022 | |
| Mayne Pharma Commercial LLC | $171.60 | 2021-2025 | |
| Shield Therapeutics INC | $153.69 | 2023-2025 | Accrufer |
| Takeda Pharmaceuticals U.S.A., INC. | $149.14 | 2019-2025 | Trintellix |
| Biogen, INC. | $137.49 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $106.62 | 2020-2023 | |
| Covidien LP | $94.19 | 2019 | |
| Agile Therapeutics, INC. | $78.09 | 2022-2023 | Twirla |
| Hologic Sales and Service, LLC | $64.41 | 2020-2025 | Fluent Fluid Management System |
| Organon LLC | $52.97 | 2023-2025 | Nexplanon |
| Aspira Women'S Health INC | $52.38 | 2019-2022 | |
| Millicent US INC | $45.60 | 2024-2025 | Femlyv, Femring, Intrarosa |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $45.39 | 2025 | Auto Suture |
| Therapeuticsmd, INC. | $41.54 | 2019-2022 | |
| Lilly USA, LLC | $33.05 | 2021-2024 | Zepbound, Jardiance |
| Currax Pharmaceuticals LLC | $25.72 | 2020-2021 | |
| Allergan, INC. | $22.80 | 2019-2020 | |
| Dexcom, INC. | $22.25 | 2025 | Dexcom G6 Transmitter |
| Shire North American Group INC | $20.76 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.36 | 2025 | |
| Exeltis, USA INC. | $18.09 | 2020 | |
| Axsome Therapeutics, INC. | $16.40 | 2023 | Auvelity |
| Amag Pharmaceuticals, INC. | $15.90 | 2019 | |
| Acella Pharmaceuticals, LLC | $14.03 | 2019 | |
| Intuitive Surgical, INC. | $9.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tykocki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.